Patents by Inventor Stephanie Planque

Stephanie Planque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoglobulins directed to bacterial, viral and endogenous polypetides
    Patent number: 12071471
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphylococcus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: August 27, 2024
    Assignee: COVALENT BIOSCIENCE INCORPORATED
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi
  • Immunoglobulins Directed to Bacterial, Viral and ENDOGENOUS Polypetides
    Publication number: 20190144528
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphylococcus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Application
    Filed: May 14, 2018
    Publication date: May 16, 2019
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi
  • Immunoglobulins directed to bacterial, viral and endogenous polypeptides
    Patent number: 9969797
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphyloccus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 15, 2018
    Assignee: Covalent Bioscience Incorporated
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi
  • TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES
    Publication number: 20160168235
    Abstract: The present invention provides transthyretin amyloid-selective and polyreactive catabodies and method of use thereof.
    Type: Application
    Filed: July 21, 2014
    Publication date: June 16, 2016
    Inventors: Sudhir Paul, Yasuhiro Nishiyama, Stephanie Planque
  • Immunoglobulins directed to bacterial, viral and endogeneous polypeptides
    Publication number: 20100183614
    Abstract: Disclosed are antibodies (immunoglobulins) and fragments thereof that hydrolyze or bind polypeptide antigens belonging to Staphyloccus aureus, hepatitis C virus, human immunodeficiency virus and Alzheimer's disease. Also disclosed are novel methods to improve the antigen reactivity of the immunoglobulins and to treat a pathophysiological condition using the immunoglobulins as therapeutics.
    Type: Application
    Filed: October 23, 2009
    Publication date: July 22, 2010
    Inventors: Sudhir Paul, Stephanie Planque, Yasuhiro Nishiyama, Eric L. Brown, Keri C. Smith, Hiroaki Taguchi
  • Binary epitope antibodies and B cell superantigen immune stimulants
    Publication number: 20090117115
    Abstract: Provided herein are dual epitope polypeptides and electrophilic analogs thereof having a superantigenic epitope and at least one other epitope effective to induce the production of antibodies with binary specificity for the epitopes on a polypeptide antigen. Also, provided are electrophilic analogs of polyclonal B cell stimulants or lipids, polysaccharides and lipopolysaccharides or nucleotides. In addition, provided herein are methods for increasing production of binary epitope specific antibodies recognizing B cell polypeptide antigens, for stimulating production of antibodies using one or more of the polypeptides or electrophilic analogs and for isolating binary epitope specific antibodies or fragments thereof. Further provided are the antibodies so produced and methods of treating HIV using the same.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 7, 2009
    Inventors: Sudhir Paul, Yasuhiro Nishiyama, Stephanie Planque